117 related articles for article (PubMed ID: 37493925)
1. Maintenance Treatment in Acute Lymphoblastic Leukemia: A Clinical Primer.
Krishnan S; Mahadevan A; Mungle T; Gogoi MP; Saha V
Indian J Pediatr; 2024 Jan; 91(1):47-58. PubMed ID: 37493925
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic metabolism presenting as a recalcitrant case of hand-foot syndrome and mucositis.
Kwan KR; Skokan S; Blesh-Boren T; Vogel J; Harter N; Ford JB
J Oncol Pharm Pract; 2024 Apr; 30(3):584-588. PubMed ID: 38204187
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic modeling of maintenance therapy for childhood acute lymphoblastic leukemia.
Gebhard A; Lilienthal P; Metzler M; Rauh M; Sager S; Schmiegelow K; Toksvang LN; Zierk J
Sci Rep; 2023 Jul; 13(1):11749. PubMed ID: 37474565
[TBL] [Abstract][Full Text] [Related]
4. Profound Hypoglycemia and High Anion Gap Metabolic Acidosis in a Pediatric Leukemic Patient Receiving 6-Mercaptopurine.
O'Shea M; Kuhn A; Creo AL; Kohorst M; Ferdjallah A
Children (Basel); 2024 Jan; 11(2):. PubMed ID: 38397272
[TBL] [Abstract][Full Text] [Related]
5. What Adherence to 6-Mercaptopurine in Patients With Acute Lymphoblastic Leukemia Tells Us: A Systematic Review.
Kodali N; Blanchard I; Zaino ML; Feldman SR
J Cutan Med Surg; 2024; 28(1):82-83. PubMed ID: 37964499
[No Abstract] [Full Text] [Related]
6. Hybrid Email and Outpatient Clinics to Optimize Maintenance Therapy in Acute Lymphoblastic Leukemia.
Mungle T; Mahadevan A; Das P; Mehta AK; Gogoi MP; Jana B; Ghara N; Ghosh D; Saha V; Krishnan S
J Pediatr Hematol Oncol; 2024 Jan; 46(1):39-45. PubMed ID: 38096154
[TBL] [Abstract][Full Text] [Related]
7. Zinc-doped hydroxyapatite as a pH responsive drug delivery system for anticancer drug 6-mercaptopurine.
Jakubowski M; Majchrzycki Ł; Zarkov A; Voelkel A; Sandomierski M
J Biomed Mater Res B Appl Biomater; 2024 Mar; 112(3):e35395. PubMed ID: 38433609
[TBL] [Abstract][Full Text] [Related]
8. Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org.
Taylor ZL; Miller TP; Poweleit EA; DeGroote NP; Pommert L; Awoniyi O; Board SG; Ugboh N; Joshi V; Ambrosino N; Chavana A; Bernhardt MB; Schafer ES; O'Brien MM; Castellino SM; Ramsey LB
Clin Transl Sci; 2023 Nov; 16(11):2130-2143. PubMed ID: 37503924
[TBL] [Abstract][Full Text] [Related]
9. Impact of Mercaptopurine Metabolites on Disease Outcome in the AIEOP-BFM ALL 2009 Protocol for Acute Lymphoblastic Leukemia.
Franca R; Stocco G; Kiren V; Tessitore A; Fagioli F; Quarello P; Bertorello N; Rizzari C; Colombini A; Bettini LR; Locatelli F; Vinti L; Girardi K; Silvestri D; Valsecchi MG; Decorti G; Rabusin M
Clin Pharmacol Ther; 2023 Nov; 114(5):1082-1092. PubMed ID: 37550838
[TBL] [Abstract][Full Text] [Related]
10. Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review.
Locatelli F; Shah B; Thomas T; Velasco K; Adedokun B; Aldoss I; Gore L; Hoelzer D; Bassan R; Park JH; Boissel N; Kantarjian H
Leuk Lymphoma; 2023 Oct; 64(10):1615-1633. PubMed ID: 37526512
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Microenvironment and therapy-resistance in leukemias.
Friedmann R; Kim YM; Konopleva M
Front Oncol; 2023; 13():1244642. PubMed ID: 37519784
[No Abstract] [Full Text] [Related]
12. Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus.
Athanassiou P; Athanassiou L
Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511872
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the Immune System: Current and Emerging Immunotherapy Strategies for Pediatric Acute Lymphoblastic Leukemia.
Glasser CL; Chen J
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509525
[TBL] [Abstract][Full Text] [Related]
14. Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality.
Kempen JH; Newcomb CW; Washington TL; Foster CS; Sobrin L; Thorne JE; Jabs DA; Suhler EB; Rosenbaum JT; Sen HN; Levy-Clarke GA; Nussenblatt RB; Bhatt NP; Lowder CY; Goldstein DA; Leiderman YI; Acharya NR; Holland GN; Read RW; Dunn JP; Dreger KA; Artornsombudh P; Begum HA; Fitzgerald TD; Kothari S; Payal AR; Daniel E; Gangaputra SS; Kaçmaz RO; Liesegang TL; Pujari SS; Khachatryan N; Maghsoudlou A; Suga HK; Pak CM; Helzlsouer KJ; Buchanich JM;
Ophthalmology; 2023 Dec; 130(12):1258-1268. PubMed ID: 37499954
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Wood BL; Devidas M; Summers RJ; Chen Z; Asselin B; Rabin KR; Zweidler-McKay PA; Winick NJ; Borowitz MJ; Carroll WL; Raetz EA; Loh ML; Hunger SP; Dunsmore KP; Teachey DT; Winter SS
Blood; 2023 Dec; 142(24):2069-2078. PubMed ID: 37556734
[TBL] [Abstract][Full Text] [Related]
16. CBD-oil as a potential solution in case of severe tamoxifen-related side effects.
Buijs SM; Braal CL; Buck SAJ; van Maanen NF; van der Meijden-Erkelens LM; Kuijper-Tissot van Patot HA; Hoop EO; Saes L; van den Boogerd SJ; Struik LEM; van Rossum-Schornagel QC; Mathijssen RHJ; Koolen SLW; Jager A
NPJ Breast Cancer; 2023 Aug; 9(1):63. PubMed ID: 37543688
[TBL] [Abstract][Full Text] [Related]
17. Accelerated cystogenesis by dietary protein load is dependent on, but not initiated by kidney macrophages.
Sedaka R; Huang J; Yamaguchi S; Lovelady C; Hsu JS; Shinde S; Kasztan M; Crossman DK; Saigusa T
Front Med (Lausanne); 2023; 10():1173674. PubMed ID: 37538309
[TBL] [Abstract][Full Text] [Related]
18. Modulation of host glutamine anabolism enhances the sensitivity of small cell lung cancer to chemotherapy.
Kodama M; Toyokawa G; Sugahara O; Sugiyama S; Haratake N; Yamada Y; Wada R; Takamori S; Shimokawa M; Takenaka T; Tagawa T; Kittaka H; Tsuruda T; Tanaka K; Komatsu Y; Nakata K; Imado Y; Yamazaki K; Okamoto I; Oda Y; Takahashi M; Izumi Y; Bamba T; Shimizu H; Yoshizumi T; Nakayama KI
Cell Rep; 2023 Aug; 42(8):112899. PubMed ID: 37531252
[TBL] [Abstract][Full Text] [Related]
19. Clival Defect Resulting in Spontaneous Cerebrospinal Fluid Rhinorrhea: Case Report and Review of Literature.
Aljawi M; Shkoukani M
Case Rep Otolaryngol; 2023; 2023():3205191. PubMed ID: 37529350
[TBL] [Abstract][Full Text] [Related]
20. Both epilepsy and anti-seizure medications affect bone metabolism in children with self-limited epilepsy with centrotemporal spikes.
Shi XY; Ju J; Lu Q; Hu LY; Tian YP; Guo GH; Liu ZS; Wu GF; Zhu HM; Zhang YQ; Li D; Gao L; Yang L; Wang CY; Liao JX; Wang JW; Zhou SZ; Wang H; Li XJ; Gao JY; Zhang L; Shu XM; Li D; Li Y; Chen CH; Zhang XJ; Zhong JM; Zhai QX; Sun YH; Lin XF; Ren RN; Yin F; Chen YH; Jia FY; Yang ZX; Wang JL; Xia ZZ; Wang LW; Luo R; Zou LP
Epilepsia; 2023 Oct; 64(10):2667-2678. PubMed ID: 37522416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
